drugset / Trial / NCT00522925
A Trial to Evaluate the Safety and Efficacy of PS433540 to Treat Hypertension
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of the study is to see if PS433540 lowers blood pressure better than placebo and to see how safe PS433540 is compared to placebo.
Timeline
- Start
- 2007-08
- Primary completion
- 2008-04
- Completion
- 2008-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sparsentan | Small molecule | 200 mg | — |
| Subject | Sparsentan | Small molecule | 500 mg | — |